Back Refine search Reset
Please choose a search criteria from below
Filters Clear all

85 results found in London

Sort by:
Showing 41 - 50 of 85 results
17 years of experience
Breast Cancer, Medical Oncology

Dr Amna Sheri is a Consultant Medical Oncologist based in London. She manages all aspects of systemic therapy for early and advanced breast cancer including adjuvant therapy, neo-adjuvant therapy, immunotherapy, treatment of secondary breast cancer, novel biological and targeted therapies and breast cancer in young women.

Dr Sheri graduated from Imperial College London in 2004 and trained in Medical Oncology at the Royal Marsden Hospital. Following this, she was awarded an MD research degree from the Institute of Cancer Research for her work into the prediction of outcome following neo-adjvuant therapy. In 2015, she appointed as a Consultant Medical Oncologist specialising in Breast Cancer and Melanoma at the Royal Free Hospital.

Dr Sheri is actively involved in research particularly on the use of prognostic and predictive biomarkers in early breast cancer. She has published extensively in peer-reviewed journals and presented her work at both national and international meetings.

Diseases, Medical Tests and Treatments

  • Biological Therapy
  • Chemotherapy
  • Clinical Trials
  • Hormone Therapy
  • Immunotherapy
  • Neoadjuvant
  • Targeted Therapy
  • Breast Cancer
  • Breast Cancer in Young Women
  • Pregnancy Assocaited Breast Cancer
  • Melanoma
Read more
22 years of experience

Dr Siamak Arami is a Consultant Haematologist at London North West University Healthcare trust since 2015 and an honorary senior clinical lecturer in haematology for Imperial College London, previously holding a post as a consultant haematologist in Kings College Hospital in London, developing a particular interest in leukaemia and myeloproliferative disorders. Dr Arami also pioneered the digital chemotherapy healthcare solution project in Kings College hospital and monitored the very first patient in UK with chemotherapy healthcare application on Apple technology.

Dr Arami qualified in Medicine in 2000, conducting immunology research at Royal Free Hospital, London in primary immunodeficiency syndromes in National Research Institute under World Health Organisation program. He specialised in haematology at the St Marys Hospital London and Northern deanery, receiving his membership of the Royal College of Physicians and the Royal College of Pathologists in 2008 and 2013, respectively. He completed his post-graduate fellowship in haematological cancers and stem cell transplantation at Fred Hutchinson Cancer Research Center and University of Washington in Seattle, USA.

Dr Arami’s research interests include digital health technology and management of patients with leukaemia and myeloproliferative disorders. He has been an investigator in a large number of practice-changing national and international trials with publications in international peer-reviewed journals . Dr Arami is the lead for myeloproliferative disorders and chronic myeloid leukaemia at London North West University Healthcare NHS trust. He is also the College tutor for Haematology training at London North West Healthcare NHS Trust.

As well as being a keen tennis player, Dr Arami enjoys travelling, organizing cancer charity events and spending time with his family.

Diseases, Medical Tests and Treatments
  • Paraprotein investigation
  • Chemotherapy
  • Targeted therapy and Immunotherapy
  • Lymphadenopathy investigations
  • anticoagulation
  • Venesection
  • General Haematology
  • Blood cancers
  • Anaemia
  • High and low white cell counts
  • High and low platelet counts
  • Blood clots
  • Bleeding
  • Haemochromatosis
  • Leukaemia
  • Polycythaemia
  • Myelodysplasia
  • Lymphomas
  • Myeloma
  • Lymph node
  • Anticoagulation
  • DVT

Read more

Dr Dionysis Papadatos-Pastos is a Consultant Medical Oncologist at University College London Hospitals and Clinical Lead for Acute Oncology at Princess Alexandra Hospital, with specialist interests in the treatment of Lung Cancer and Mesothelioma.

Dr Papadatos-Pastos graduated with First Class honours in both Medicine at the University of Athens and his PhD in Medical Oncology in 2012, completing his medical oncology training at Guy’s and St Thomas’, St George’s University Hospitals and The Royal Marsden and undertaking his specialist certificate in Medical Oncology at the Institute of Cancer Research at the University of London.

Dr Papadatos-Pastos has conducted formal research into prognostic and predictive biomarkers, and the combination of immunotherapy drugs with novel compounds, participating in a number of drug trials, presenting his findings at conferences worldwide and publishing in peer-reviewed journals, including the Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer. He has also received the ASCO merit award in 2010.










Diseases, Medical Tests and Treatments
  • Development of novel targeted therapies for the treatment of lung cancer
  • Assessment pf combinations of immunotherapy drugs with other anti-cancer compounds
  • Lung
  • Nonsmall cell lung
  • Small cell lung cancer
  • Malignant mesothelioma
Read more
27 years of experience
Bowel Cancer, Cancer of Unknown Primary, Clinical Oncology + 6more

Dr Riyaz Shah is a Consultant Medical Oncologist at The Harley Street Clinic and Maidstone and Tunbridge Wells NHS Trust. He specialises in lung and gastrointestinal cancers and malignant mesothelioma.

Dr Shah completed his medical degree at the University of London and obtained a First Class Honours Intercalated BSc in Experimental Pathology. Following this he undertook further medical training at The London Chest Hospital, Hammersmith Hospital, University College London, Guy’s Hospital and The Royal Marsden. In 1997 he became a member of the Royal College of Physicians of London. He undertook a Clinical Research Fellowship with The Imperial Cancer Research Fund to investigate abnormal genes in pancreatic cancer. This work led to him being awarded with a PhD by Imperial College London. Following this, Dr Shah trained to become a specialist in Medical Oncology at The Royal Marsden Hospital and was awarded an ASCO Foundation Merit Award. In 2006 he was appointed Consultant Medical Oncologist at the Kent Oncology Centre.

Dr. Shah is actively involved in training future medical oncologists and has an extensive role in clinical research. He has been a principal investigator on many trials at his centre and has been instrumental in the introduction of immunotherapy into routine clinical practice within Kent. He has served on the NCRI Lung Group, acted as chairman of the Kent Lung Network Lead and continues to be the lead for research at his Cancer Centre. He has been published widely and is regularly asked to speak both nationally and internationally on cancer issues.

Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Immunotherapy 
  • Cancer of Unknown Primary 
  • Colorectal Cancer 
  • Gastro-intestinal Cancers 
  • Lung Cancer 
  • Thoracic Cancer
  • Acute Oncology
Read more
38 years of experience

Professor Daniel Hochhauser is a specialist in the treatment of gastrointestinal cancer, conducting research which focuses on the development of novel therapeutics.



Professor Hochhauser qualified in medicine from Cambridge and the Royal Free Hospital Medical School. Following postgraduate training, he was appointed Clinical Fellow in Medical Oncology at the Institute of Molecular Medicine, Oxford where he completed a DPhil, subsequently training at Memorial Sloan Kettering Cancer Center New York before appointment as a consultant in 1996. 

Diseases, Medical Tests and Treatments
  • Home chemotherapy


  • Gastrointestinal cancers (chemotherapy)
  • Upper gastrointestinal cancers
  • Lower gastrointestinal cancers
Read more
16 years of experience
Anal Cancer, Bile Duct Cancer (Cholangiocarcinoma), Biliary Cancer + 7more

Dr Neel Bhuva is a Consultant Clinical Oncologist with an interest in in the specialist non-surgical management of upper and lower gastrointestinal malignancies and general/acute oncology. He is also able to advice on the treatment for cancers of an unknown primary. He has extensive experience delivering radiotherapy, including stereotactic radiotherapy with ‘Cyberknife’, chemotherapy, biological targeted therapy and immunotherapy treatment.

After graduating from Imperial College London, Dr Bhuva undertook his junior medical training at the Hammersmith and Charing Cross Hospitals. Following this, he completed 7 years of specialist training at Mount Vernon, North Middlesex, Imperial College and University College London Hospitals. During this time he completed a Fellowship in radiotherapy at the Royal Marsden Hospital and a postgraduate Master’s degree in Oncology at the Institute of Cancer Research.

Dr Bhuva is a Member of the Royal College of Physicians and a Fellow of the Royal College of Radiologists. He teaches oncology students in London and is an assessor for the Royal College of Radiologists Final Fellowship examination. He is highly active in clinical research and has been published extensively in peer reviewed journals. He is also regularly invited to present his work an both national and international conferences.

He is also a member of the American Society of Clinical Oncology (ASCO) and the European Organisation for Research and Treatment of Cancer (EORTC – Gastrointestinal cancer and Radiation Oncology group).

Diseases, Medical Tests and Treatments

  • Biological Therapy 
  • Chemotherapy 
  • Immunotherapy
  • Radiotherapy 
  • Bowel Cancer 
  • Cancer of Unknown Primary 
  • Gastro-intestinal Cancers 
  • Stomach Cancer 
Read more
Recommended by 1 specialist
17 years of experience
Haematological Malignancy

Dr Joel Newman is a Consultant Haematologist currently working in London and the South East, consulting at The LOC on Harley Street, The Harley Street Clinic, London Bridge Hospital, HCA The Shard Diagnostic Center and HCA at Guy's Cancer Centre. Outside of London he consults a the Nuffield Hospitals in Tunbridge Wells, Brighton and Haywards Heath, as well as the Spire Sussex Hospital. His current NHS post is at East Sussex Healthcare Trust. His areas of interest include Diagnosis and treatment of blood cancers including chemotherapy administration (leukaemia, myeloma, lymphoma); anaemia; iron deficiency and bleeding disorders.

Dr Newman is a Fellow of the Royal College of Physicians and a Fellow of the Royal College of Pathologists. Dr Newman trained at Guy's and St.Thomas' Hospitals in London, working throughout the South East of England, including specialist training in Haematology at King's College Hospital.

In addition, Dr Newman was a Specialist Advisor to the Care Quality Commission, influenced the Education and Training of new Haematologists via the London Deanery and the Royal College of Pathologists, and was Chair of the East Sussex Division of the British Medical Association. He is also an author of several textbook sections on Haematology, and was Deputy Editor for the Journal of Medical Case Reports. He is currently Chief of Core Services and Laboratory Director at East Sussex Healthcare, and Clinical Lead for the Sussex Pathology Network.

Diseases, Medical Tests and Treatments

  • Diagnosis and treatment of blood cancers including chemotherapy administration
  • Investigation of excessive fatigue and tiredness
  • Bone marrow aspirate and biopsy
  • Monitoring of anticoagulation including warfarin and newer anticoagulants
  • Bone Marrow Transplant
  • Anaemia
  • Iron deficiency
  • Bleeding disorders
  • Unexplained blood clots
  • Myelodysplastic syndromes
  • Myeloproliferative disorders (polycythaemia, essential thrombocythaemia, myelofibrosis)
  • Lymphoma
  • Blood Cancer
  • Hodgkin's Lymphoma
  • Chronic Lymphocytic Leukaemia

Read more
Offers video consultation
21 years of experience
Colorectal Cancer, Anal Cancer, Bile Duct Cancer (Cholangiocarcinoma) + 6more

Dr Khan is a research-active consultant who trained in medical oncology at the Northern Ireland Cancer Centre and Royal Marsden NHS Foundation Trust London. After working as a Locum Consultant at Royal Marsden for 21 months, he took substantive consultant position in Gastrointestinal Oncology at UCLH. He also attends North Middlesex University Hospital (NMUH), where he is the Clinical Lead of Carcinoma of Unknown Primary (CUP) and Clinical Research in Oncology. Dr Khan was awarded the Robert McAlpine fellowship and studied mechanisms of response and resistance to targeted therapies in advanced colorectal cancer. He gained an MD(Res) degree under the supervision of Professor David Cunningham at the Institute of Cancer Research and the Royal Marsden Hospital. He was involved in setup and conduct of large multi-centre academic and translational studies from the time that he spent in full-time research, which included working as a trial physician for phase II/III studies in early and advanced gastrointestinal cancers.

Dr Khan's main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

He presented and lectured in international conferences and public forums respectively. He published several high impact papers in peer-reviewed journals including Science, Cancer Discovery, Cancer Cell, Gut, Gastroenterologist, Clinical Cancer Research, Oncogene, Oncologist, BMC Medicine, BMC Cancer, British Medical Journal (BMJ) and British Journal of Cancer. He also served as an expert member of the National Research and Ethics Committee.

Dr Khan also played an active role in improving the educational experience of the junior doctors nationally. He writes questions for MRCP(UK) and Medical Oncology exams and remains part of the national medical oncology recruitment panel. Dr Khan's publications can be accessed via the link below:

Dr Khan's seceratary Alanna Sarwar can be approached at +44(0)207 317 2659 and she can be emailed directly at

Diseases, Medical Tests and Treatments

  • Gastrointestinal Cancer Research
  • Colorectal cancers 
  • Colon cancers
  • Rectal cancers
  • Anal cancers 
  • Upper GI Cancers
  • Gastric cancers
  • oesophageal cancers
  • Hepato-biliary malignancies
  • Cholangiocarcinoma
  • Gall bladder cancers
  • Pancreatic cancers
  • Carcinoma of Unknown Primary
  • Gastrointestinal Cancer Research
  • Colorectal cancer
  • Newly diagnosed cancers
  • Molecular Genetics
  • Liquid Biopsies

Read more
19 years of experience
Clinical Oncology, Lung Cancer, Mesothelioma + 2more

Dr Wilson is a Consultant Clinical Oncologist specialising in the treatment of thoracic malignancies (non-small cell lung cancer, small-cell lung cancer, mesothelioma, thymoma). He also offers radiotherapy for skin cancers (basal cell carcinoma, squamous cell carcinoma).

James Wilson completed his DPhil (PhD) at the University of Oxford in 2015, having been awarded a Cancer Research UK/Engineering and Physical Sciences Research Council fellowship. He finished his training at the Royal Marsden Hospital and was awarded a prestigious National Institute for Health Research Clinical Lectureship position at The Institute of Cancer Research in 2016. He is a member of the Royal College of Physicians and fellow of the Royal College of Radiologists.

He is a core member of the oligometastatic multi-disciplinary team (MDT) and offers stereotactic radiotherapy for primary and secondary lung cancers and metastases to the spine, bone and other sites. He represents clinical oncology at the specialist spinal tumour MDT at the National Hospital for Neurology and Neurosurgery.

Dr Wilson has worked in London's leading cancer centres. He is a Consultant Clinical Oncologist at University College London Hospital. As an Associate Professor at UCL he is leading research to improve treatment outcomes for patients. Dr Wilson is a specialist committee member for NICE (National Institute for Health and Care Excellence).

Diseases, Medical Tests and Treatments

  • Thymoma
  • Thymic carcinoma
  • Non-small cell lung cancer
  • Small cell lung cancer
Read more

Dr Karavasilis is part of the sarcoma team at UCLH, specialising in the systemic treatment of adult patients with various types of sarcomas, including bone sarcomas and GISTs. He is also Assistant Professor of Oncology at Aristotle University of Thessaloniki, Greece and was previously their director of the Medical Oncology.

Dr Karavasilis has a strong interest in clinical and translational research in sarcomas, particularly looking for novel agents for the treatment of this type of cancer. He also has over 15 years’ experience in clinical trials.

Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Sarcoma
  • Soft Tissue Sarcoma
Read more